North Star Investment Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128 | Hold |
14
| – | – | ﹤0.01% | 1188 |
|
|
2025
Q1 | $111 | Hold |
14
| – | – | ﹤0.01% | 1174 |
|
|
2024
Q4 | $76 | Hold |
14
| – | – | ﹤0.01% | 1199 |
|
|
2024
Q3 | $101 | Hold |
14
| – | – | ﹤0.01% | 1162 |
|
|
2024
Q2 | $152 | Sell |
14
-150
| -91% | -$1.63K | ﹤0.01% | 1133 |
|
|
2024
Q1 | $3.07K | Sell |
164
-30
| -15% | -$562 | ﹤0.01% | 1044 |
|
|
2023
Q4 | $4.2K | Hold |
194
| – | – | ﹤0.01% | 966 |
|
|
2023
Q3 | $3.99K | Hold |
194
| – | – | ﹤0.01% | 983 |
|
|
2023
Q2 | $9.12K | Buy |
194
+180
| +1,286% | +$8.46K | ﹤0.01% | 867 |
|
|
2023
Q1 | $587 | Hold |
14
| – | – | ﹤0.01% | 1225 |
|
|
2022
Q4 | $534 | Hold |
14
| – | – | ﹤0.01% | 1232 |
|
|
2022
Q3 | $1K | Hold |
14
| – | – | ﹤0.01% | 1098 |
|
|
2022
Q2 | $0 | Hold |
14
| – | – | ﹤0.01% | 1173 |
|
|
2022
Q1 | $0 | Hold |
14
| – | – | ﹤0.01% | 1198 |
|
|
2021
Q4 | $1K | Hold |
14
| – | – | ﹤0.01% | 1148 |
|
|
2021
Q3 | $1K | Hold |
14
| – | – | ﹤0.01% | 1094 |
|
|
2021
Q2 | $1K | Hold |
14
| – | – | ﹤0.01% | 1067 |
|
|
2021
Q1 | $1K | Hold |
14
| – | – | ﹤0.01% | 1028 |
|
|
2020
Q4 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 1003 |
|